Strategic asset sale AMD Global Telemedicine has recently divested several assets including the AGNES Connect software and related IP, customer subscriptions, and goodwill to UniDoc Health Corp. This indicates a potential shift in technology stack and product offerings, presenting an opportunity to engage UniDoc or target customers impacted by the transition for replacement or migration partnerships.

AI interoperability A 2024 partnership with Carefluence emphasizes interoperability capabilities. This suggests a market need for seamless data exchange and integration with existing EHRs and systems, creating a sales angle around interoperability enhancements, standards alignment, and powered integration services.

leadership change Appointment of a new president in 2024 signals possible strategic pivots and renewed focus on growth opportunities. This can be leveraged to approach the leadership team with refreshed value props, onboarding programs, and joint go-to-market plans.

Global telemedicine leader With a three-decade track record and a focus on expanding reach to patients irrespective of location, AMD positions itself as a mature partner for health systems seeking scalable telemedicine platforms, remote patient monitoring, and clinician-to-patient connected care solutions.

Revenue positioning Reported revenue range of 10 to 25 million places AMD in the mid-market, presenting a clear target for mid-size health systems and multi-facility organizations seeking scalable, enterprise-grade telemedicine deployments and managed services.